| Product Code: ETC9974382 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Precision Psychiatry Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Precision Psychiatry Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Precision Psychiatry Market - Industry Life Cycle |
3.4 United States (US) Precision Psychiatry Market - Porter's Five Forces |
3.5 United States (US) Precision Psychiatry Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Precision Psychiatry Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 United States (US) Precision Psychiatry Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.8 United States (US) Precision Psychiatry Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 United States (US) Precision Psychiatry Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Precision Psychiatry Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of mental health disorders in the US |
4.2.2 Growing awareness and acceptance of precision psychiatry as an effective treatment approach |
4.2.3 Technological advancements in precision medicine and personalized treatment options |
4.3 Market Restraints |
4.3.1 High costs associated with precision psychiatry treatments |
4.3.2 Limited insurance coverage for precision psychiatry services |
4.3.3 Regulatory challenges and uncertainties surrounding precision psychiatry practices |
5 United States (US) Precision Psychiatry Market Trends |
6 United States (US) Precision Psychiatry Market, By Types |
6.1 United States (US) Precision Psychiatry Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Precision Psychiatry Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Precision Psychiatry Market Revenues & Volume, By Products, 2021- 2031F |
6.1.4 United States (US) Precision Psychiatry Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United States (US) Precision Psychiatry Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Precision Psychiatry Market Revenues & Volume, By Genetic Biomarker, 2021- 2031F |
6.2.3 United States (US) Precision Psychiatry Market Revenues & Volume, By Protein Biomarker, 2021- 2031F |
6.3 United States (US) Precision Psychiatry Market, By Sample |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Precision Psychiatry Market Revenues & Volume, By Blood-Based, 2021- 2031F |
6.3.3 United States (US) Precision Psychiatry Market Revenues & Volume, By Non-Blood-Based, 2021- 2031F |
6.4 United States (US) Precision Psychiatry Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Precision Psychiatry Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.4.3 United States (US) Precision Psychiatry Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.4.4 United States (US) Precision Psychiatry Market Revenues & Volume, By Autism, 2021- 2031F |
6.4.5 United States (US) Precision Psychiatry Market Revenues & Volume, By Depression, 2021- 2031F |
6.4.6 United States (US) Precision Psychiatry Market Revenues & Volume, By Bipolar Disease, 2021- 2031F |
6.4.7 United States (US) Precision Psychiatry Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Precision Psychiatry Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Precision Psychiatry Market Revenues & Volume, By Hospitals and Diagnostic Laboratories, 2021- 2031F |
6.5.3 United States (US) Precision Psychiatry Market Revenues & Volume, By Academic and Research Institutions, 2021- 2031F |
6.5.4 United States (US) Precision Psychiatry Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Precision Psychiatry Market Import-Export Trade Statistics |
7.1 United States (US) Precision Psychiatry Market Export to Major Countries |
7.2 United States (US) Precision Psychiatry Market Imports from Major Countries |
8 United States (US) Precision Psychiatry Market Key Performance Indicators |
8.1 Patient outcomes improvement rate through precision psychiatry interventions |
8.2 Adoption rate of precision psychiatry practices by mental health professionals in the US |
8.3 Research and development investment in precision psychiatry technologies and treatments |
8.4 Patient satisfaction and engagement levels with precision psychiatry services |
9 United States (US) Precision Psychiatry Market - Opportunity Assessment |
9.1 United States (US) Precision Psychiatry Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Precision Psychiatry Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 United States (US) Precision Psychiatry Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.4 United States (US) Precision Psychiatry Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 United States (US) Precision Psychiatry Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Precision Psychiatry Market - Competitive Landscape |
10.1 United States (US) Precision Psychiatry Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Precision Psychiatry Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here